Candida Infections
📧 Sign up to get email alerts when something new happens for Candida Infections.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-28FDA Approved: POSACONAZOLE — Original Application (i3 Pharmaceuticals, LLC)
FDA approved an original application for posaconazole from i3 Pharmaceuticals, LLC (generic posaconazole).
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers [Phase 1]
Phase I pharmacokinetic comparison study of Vorico Injection 200mg versus Vfend IV 200mg in healthy volunteers completed with posted results…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine [Phase 1]
Phase 1 trial assessing adjuvant effect and route of administration on safety and immunogenicity of the NDV-3 vaccine; completed with result…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Antimicrobial Photodynamic Therapy Associated With the Conventional Endodontic Treatment: A Clinical and Microbiological Study [NA]
Completed clinical trial evaluating antimicrobial photodynamic therapy as an adjunct to conventional endodontic treatment for dental infecti…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients [Phase 4]
Phase 4 trial evaluating antifungal prophylaxis in ICU patients to prevent fungal infections, including Candida infections, has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2008-06-16Clinical Trial Update: Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients [Phase 4]
Phase 4 clinical trial update evaluating preemptive treatment with Ambisome (liposomal amphotericin B) to prevent Candida colonization in se…
-
FDA approval · 2006-08-10FDA Approved: ANCOBON — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for ANCOBON (flucytosine) submitted by Bausch Health US LLC.